Company beats earnings and revenue expectations, driven by strong cancer drug growth and rising demand for newer therapies.

Good morning, and welcome to Johnson & Johnson's First Quarter 2026 Earnings Conference Call. [Operator Instructions] This call is being recorded. [Operator Instructions] I will now turn the call over ...

Q1 2026 earnings call recap: sales beat, raised guidance, ICOTYDE/INLEXZO launch metrics, and key risks—read now.

Johnson & Johnson (NYSE:JNJ) Q1 2026 Earnings Call Transcript April 14, 2026 Johnson & Johnson beats earnings expectations. Reported EPS is $2.7, expectations were $2.68. Operator: Good morning, and ...

Companies ride the next wave of reshoring and nearshoring, with supply chain and labor issues at the forefront.

US stocks rose as hopes of renewed US-Iran talks boosted sentiment, with investors also tracking earnings from major ...

Monday, April 13th, 2026 We start a new trading week with plenty on our calendar — hopefully which will offer some new market narratives outside the happenings at the Strait of Hormuz and its effect ...

Oil prices are back above $100 per barrel after 21 hours of ceasefire talks between the United States and Iran failed to end ...

RIO surges 72.4% in a year, fueled by strong copper output, expanding projects and strategic moves in lithium, aluminum and ...

As the prolonged war between the United States and Iran continues to drive up exchange rates and oil prices across the board, ...

President Donald Trump said the U.S. is on the cusp of something “this country has never seen” — and he credited his ...

The Pakistani military said the delegation also included the country’s interior minister and other senior security officials.